Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.120
-0.020 (-1.75%)
At close: May 14, 2025, 4:00 PM
1.120
0.00 (0.00%)
After-hours: May 14, 2025, 4:00 PM EDT
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $11.99 million as of May 14, 2025. Its market cap has decreased by -68.60% in one year.
Market Cap
11.99M
Enterprise Value
-7.20M
1-Year Change
-68.60%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $11.99M, a decrease of -73.81%. That is a compound annual growth rate of -14.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 12.20M | -56.12% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |